Results 221 to 230 of about 137,029 (384)

Juvenile idiopathic arthritis during 20 years in Sweden: Characteristics of children, therapy interventions, occurrence of uveitis and ocular complications

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose To assess and compare the characteristics, therapy interventions, occurrence of uveitis and ocular complications in children with juvenile idiopathic arthritis (JIA) screened and examined for uveitis in Gothenburg, Sweden, over 20 years.
Pia Lundgren   +7 more
wiley   +1 more source

Clinical use of Infliximab in Crohn’s disease: the Edinburgh experience

open access: bronze, 2001
Ian Arnott   +3 more
openalex   +1 more source

Progression and topographic subtypes of Terrien marginal degeneration

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose To report long‐term outcomes and to search for immunological and genetic risk factors in Terrien marginal degeneration (TMD). Methods Retrospective, in part prospective, hospital‐based longitudinal follow‐up study of 32 eyes of 16 Finnish patients from 2012 to 2023. Median follow‐up was 7.3 years (range, 0.3–15.2).
Minna Ruutila   +8 more
wiley   +1 more source

Characterization of the Regulatory Landscape in Crohn's Disease Reveals microRNA-Associated Alterations that Shape Anti-TNF Response. [PDF]

open access: yesInflamm Bowel Dis
Cervera-Seco L   +8 more
europepmc   +1 more source

Long‐Term Outcome of Paediatric Crohn's Disease Patients With Deep Ulcerations at Diagnosis

open access: yesActa Paediatrica, EarlyView.
ABSTRACT Aim Presence of deep ulcerations (DU) at diagnosis seems to be predictive of a more severe phenotype in adult Crohn's disease (CD). The aim of our study was to investigate if the presence of DU at diagnosis was associated with a more severe disease course over time in children.
Monica S. Ronconi   +8 more
wiley   +1 more source

Treatment of active spondyloarthropathy with infliximab, the chimeric monoclonal antibody to tumour necrosis factor α [PDF]

open access: green, 2001
Filip Van den Bosch   +5 more
openalex   +1 more source

Effectiveness and Safety of a Second JAK Inhibitor in Ulcerative Colitis: The J2J Multicentre Study

open access: yesAlimentary Pharmacology &Therapeutics, EarlyView.
In total 169 patients already exposed to a JAKi and who received a second JAKi were retrospectively studied across 28 GETAID centres, with 48% reaching steroids‐free clinical remission after induction. Adverse events led to treatment discontinuation in 5% of cases.
Mathilde Osty   +56 more
wiley   +1 more source

Dashboard-Guided Anti-TNF Induction: An Effective Strategy to Minimize Immunogenicity While Avoiding Immunomodulators-A Single-Center Cohort Study. [PDF]

open access: yesCrohns Colitis 360
Céspedes-Martínez E   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy